This inventor holds 5 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Universität De Barcelona, Fundacio Institut De Recerca Biomedica (Irb Barcelona), Iproteos S.l.. Active years: 2009-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sant Just Desvern, ES (2011 - 2016)
- Barcelona, ES (2009 - 2020)
Company Filing History:


Years Active: 2009-2020
Title: Discovering the Innovations of Ernest Giralt Lledó
Introduction
Ernest Giralt Lledó is a prominent inventor based in Barcelona, Spain, known for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, he focuses on innovative compounds that have the potential to address cognitive disorders and other medical concerns.
Latest Patents
Among his latest inventions are the 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives. This innovative product involves compounds that exhibit pharmacological activity, and it includes processes for preparation, pharmaceutical compositions, and therapeutic uses aimed specifically at the therapy and prophylaxis of cognitive disorders.
Career Highlights
Throughout his career, Ernest has collaborated with esteemed institutions such as the University of Barcelona and Iproteos S.L. His patents reveal a commitment to advancing the life sciences, particularly in the search for effective treatments for various cognitive impairments.
Collaborations
Ernest Giralt Lledó has worked alongside notable colleagues, including Roger Prades Cosano and Teresa Tarragó Clua, contributing to a collaborative environment that fosters innovation and research in pharmaceuticals.
Conclusion
Ernest Giralt Lledó exemplifies the role of inventors in driving innovation within the biomedical field. His dedication to developing new therapeutic compounds underscores the importance of research and collaboration in addressing complex medical challenges. As he continues to explore new avenues of invention, his work remains pivotal in improving patient outcomes and advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile